Detalles de la búsqueda
1.
Infections and Immunotherapy in Lung Cancer: A Bad Relationship?
Int J Mol Sci
; 22(1)2020 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33375194
2.
Systematic review and meta-analysis of immune checkpoint inhibitors as single agent or in combination with chemotherapy in early-stage non-small cell lung cancer: Impact of clinicopathological factors and indirect comparison between treatment strategies.
Eur J Cancer
; 195: 113404, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37948842
3.
Study Design and Rationale for Espera Trial: A Multicentre, Randomized, Phase II Clinical Trial Evaluating the Potential Efficacy of Adding SBRT to Pembrolizumab-Pemetrexed Maintenance in Responsive or Stable Advanced Non-Squamous NSCLC After Chemo-Immunotherapy Induction.
Clin Lung Cancer
; 23(3): e269-e272, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34470722
4.
Integrating supportive care into the multidisciplinary management of lung cancer: we can't wait any longer.
Expert Rev Anticancer Ther
; 22(7): 725-735, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35608060
5.
Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned.
Cells
; 10(10)2021 10 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34685665
6.
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic.
Eur J Cancer
; 135: 159-169, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32580131
Resultados
1 -
6
de 6
1
Próxima >
>>